DK1177167T3 - (1R,2S,4R)-(-)-2-[(2'-[(N,N,-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptan med høj renhed og farmaceutisk acceptable syreadditionssalte deraf, fremgangsmåde til fremstilling af disse forbindelser og medikamenter, der inde... - Google Patents

(1R,2S,4R)-(-)-2-[(2'-[(N,N,-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptan med høj renhed og farmaceutisk acceptable syreadditionssalte deraf, fremgangsmåde til fremstilling af disse forbindelser og medikamenter, der inde...

Info

Publication number
DK1177167T3
DK1177167T3 DK00929730T DK00929730T DK1177167T3 DK 1177167 T3 DK1177167 T3 DK 1177167T3 DK 00929730 T DK00929730 T DK 00929730T DK 00929730 T DK00929730 T DK 00929730T DK 1177167 T3 DK1177167 T3 DK 1177167T3
Authority
DK
Denmark
Prior art keywords
bicyclo
dimethylamino
ethoxy
tri
phenyl
Prior art date
Application number
DK00929730T
Other languages
Danish (da)
English (en)
Inventor
Gyula Simig
Tibor Mezei
Zoltan Budai
Marta Porcs-Makkay
Gyoergy Krasznai
Gyula Lukacs
Kalman Nagy
Donath Gyoergyi Vereczkeyne
Tibor Szabo
Norbert Nemeth
Janos Szulagyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of DK1177167T3 publication Critical patent/DK1177167T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/12—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00929730T 1999-05-11 2000-05-10 (1R,2S,4R)-(-)-2-[(2'-[(N,N,-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptan med høj renhed og farmaceutisk acceptable syreadditionssalte deraf, fremgangsmåde til fremstilling af disse forbindelser og medikamenter, der inde... DK1177167T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9901559A HU227114B1 (en) 1999-05-11 1999-05-11 (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
PCT/HU2000/000044 WO2000068183A2 (en) 1999-05-11 2000-05-10 High purity (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them

Publications (1)

Publication Number Publication Date
DK1177167T3 true DK1177167T3 (da) 2004-03-01

Family

ID=89998272

Family Applications (4)

Application Number Title Priority Date Filing Date
DK00927613T DK1177166T3 (da) 1999-05-11 2000-05-10 Fremgangsmåde til fremstilling af (1R,2S,4R)-(-)-2(2'-N,N-dimenthylamino-etoxy)-2-phenyl-1,7,7-tri-mehtyl.bicyclo-2.2.1-heptan og farmaceutisk acceptable syreadditionssalte deraf
DK00929730T DK1177167T3 (da) 1999-05-11 2000-05-10 (1R,2S,4R)-(-)-2-[(2'-[(N,N,-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptan med høj renhed og farmaceutisk acceptable syreadditionssalte deraf, fremgangsmåde til fremstilling af disse forbindelser og medikamenter, der inde...
DK00110121T DK1052245T3 (da) 1999-05-11 2000-05-10 (1R, 2S,4R)-(-)-2-[(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptan af høj renhedsgrad og farmaceutisk acceptable syretilsætningssalte deraf, fremgangsmåde til fremstilling...
DK00110122T DK1052243T3 (da) 1999-05-11 2000-05-10 Fremgangsmåde til fremstilling af (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri[methyl]-bicyclo[2.2.1]heptan og farmaceutisk acceptable syreadditionssalte deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK00927613T DK1177166T3 (da) 1999-05-11 2000-05-10 Fremgangsmåde til fremstilling af (1R,2S,4R)-(-)-2(2'-N,N-dimenthylamino-etoxy)-2-phenyl-1,7,7-tri-mehtyl.bicyclo-2.2.1-heptan og farmaceutisk acceptable syreadditionssalte deraf

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK00110121T DK1052245T3 (da) 1999-05-11 2000-05-10 (1R, 2S,4R)-(-)-2-[(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptan af høj renhedsgrad og farmaceutisk acceptable syretilsætningssalte deraf, fremgangsmåde til fremstilling...
DK00110122T DK1052243T3 (da) 1999-05-11 2000-05-10 Fremgangsmåde til fremstilling af (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri[methyl]-bicyclo[2.2.1]heptan og farmaceutisk acceptable syreadditionssalte deraf

Country Status (38)

Country Link
US (3) US6335469B1 (de)
EP (4) EP1052245B1 (de)
JP (2) JP4536265B2 (de)
KR (3) KR20060010874A (de)
CN (2) CN1173928C (de)
AR (2) AR023900A1 (de)
AT (4) ATE252544T1 (de)
AU (2) AU777737B2 (de)
BG (2) BG64673B1 (de)
BR (2) BR0010406A (de)
CA (2) CA2373193A1 (de)
CO (1) CO5170480A1 (de)
CZ (4) CZ20014050A3 (de)
DE (4) DE60038112T8 (de)
DK (4) DK1177166T3 (de)
EA (2) EA002164B1 (de)
EE (2) EE04638B1 (de)
ES (4) ES2302694T3 (de)
FR (2) FR2793489B1 (de)
HK (2) HK1031220A1 (de)
HR (2) HRP20000291B1 (de)
HU (1) HU227114B1 (de)
IL (4) IL146421A0 (de)
IS (2) IS6152A (de)
LT (2) LT4927B (de)
MX (2) MXPA01011420A (de)
MY (2) MY123523A (de)
NO (2) NO321486B1 (de)
NZ (2) NZ515918A (de)
PL (2) PL340107A1 (de)
PT (4) PT1052243E (de)
SI (4) SI1052245T1 (de)
SK (4) SK6902000A3 (de)
TR (2) TR200200148T2 (de)
TW (2) TW528742B (de)
UA (2) UA61122C2 (de)
WO (2) WO2000068183A2 (de)
ZA (2) ZA200108958B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6589996B2 (en) 2000-03-17 2003-07-08 Orion Corporation Treatment of disorders relating to the serotonergic system
US20040082665A1 (en) * 2001-01-22 2004-04-29 Outi Maki-Ikola Method for treating stress or tension
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
CA2559487A1 (en) * 2004-03-12 2005-09-22 Egis Gyogyszergyar Nyrt. Combination of deramciclane and opoids as analgesics
JP4916680B2 (ja) * 2005-06-30 2012-04-18 株式会社半導体エネルギー研究所 半導体装置の作製方法、剥離方法
US20080258121A1 (en) * 2007-04-23 2008-10-23 Hasan Farooq Fire Retardant Composition
WO2011061744A2 (en) 2009-11-19 2011-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Novel arylated camphenes, processes for their preparation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU212574B (en) * 1990-09-21 1996-08-29 Egyt Gyogyszervegyeszeti Gyar Process for producing (1r,2s)-(-)-2-phenyl-(2'-dimethyl-amino-etoxy)-1,7,7-trimethyl-bicyclo[2.2.1.]heptane
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
HU226061B1 (en) 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Also Published As

Publication number Publication date
IL146420A (en) 2007-06-03
AU776696B2 (en) 2004-09-16
DE60006097T2 (de) 2004-06-17
TR200200148T2 (tr) 2002-06-21
PL202956B1 (pl) 2009-08-31
UA49974C2 (uk) 2002-10-15
JP2002544185A (ja) 2002-12-24
EP1052243A2 (de) 2000-11-15
EP1052245A3 (de) 2001-02-28
KR100581489B1 (ko) 2006-05-22
SK6892000A3 (en) 2000-12-11
ATE237579T1 (de) 2003-05-15
LT4927B (lt) 2002-07-25
NZ515917A (en) 2004-02-27
FR2793489B1 (fr) 2004-04-02
BG104417A (en) 2001-03-30
CZ20014051A3 (cs) 2002-05-15
EP1177167B1 (de) 2003-10-22
CN1173928C (zh) 2004-11-03
JP4031203B2 (ja) 2008-01-09
WO2000068181A2 (en) 2000-11-16
WO2000068183A2 (en) 2000-11-16
CN1353686A (zh) 2002-06-12
FR2793490A1 (fr) 2000-11-17
TR200200147T2 (tr) 2002-06-21
NO20015336D0 (no) 2001-10-31
FR2793489A1 (fr) 2000-11-17
NO321486B1 (no) 2006-05-15
SK16232001A3 (sk) 2002-04-04
ZA200108956B (en) 2003-02-17
LT2001108A (en) 2002-03-25
SI1177166T1 (sl) 2008-08-31
IS6152A (is) 2001-11-09
EA002164B1 (ru) 2001-12-24
PT1052243E (pt) 2003-12-31
LT2001109A (en) 2002-03-25
KR20020010914A (ko) 2002-02-06
PL340108A1 (en) 2000-11-20
IS6153A (is) 2001-11-09
IS2570B (is) 2010-01-15
IL146420A0 (en) 2002-07-25
MY122508A (en) 2006-04-29
US20020040164A1 (en) 2002-04-04
HK1031220A1 (en) 2001-06-08
FR2793490B1 (fr) 2004-04-23
TWI286541B (en) 2007-09-11
EP1052245A2 (de) 2000-11-15
EP1177167A2 (de) 2002-02-06
DE60004126T2 (de) 2004-04-22
SK6902000A3 (en) 2000-12-11
NO20015352L (no) 2002-01-08
NO321487B1 (no) 2006-05-15
SI1052243T1 (en) 2004-02-29
EA200000411A3 (ru) 2001-02-26
LT4928B (lt) 2002-07-25
EP1177166B1 (de) 2008-02-20
DE60002117T2 (de) 2003-12-24
CZ291329B6 (cs) 2003-02-12
ES2208328T3 (es) 2004-06-16
EP1052245B1 (de) 2003-04-16
PT1052245E (pt) 2003-09-30
ES2302694T3 (es) 2008-08-01
AU777737B2 (en) 2004-10-28
ATE386714T1 (de) 2008-03-15
TW528742B (en) 2003-04-21
HRP20000291B1 (en) 2005-06-30
HRP20000290A2 (en) 2005-02-28
EE04672B1 (de) 2006-08-15
PL340107A1 (en) 2000-11-20
SK16242001A3 (sk) 2002-04-04
NZ515918A (en) 2004-02-27
CN1353687A (zh) 2002-06-12
KR20010112486A (ko) 2001-12-20
BG104416A (en) 2001-03-30
CA2373193A1 (en) 2000-11-16
PT1177166E (pt) 2008-06-02
EA002163B1 (ru) 2001-12-24
HU227114B1 (en) 2010-07-28
EP1052243A3 (de) 2001-02-28
HRP20000290B1 (en) 2007-08-31
AR020860A1 (es) 2002-05-29
CO5170480A1 (es) 2002-06-27
BG64673B1 (bg) 2005-11-30
MXPA01011423A (es) 2002-06-04
ATE252544T1 (de) 2003-11-15
AU4773100A (en) 2000-11-21
EE200100596A (et) 2003-02-17
SI1052245T1 (en) 2003-10-31
DE60038112D1 (de) 2008-04-03
EP1052243B1 (de) 2003-07-30
KR100685071B1 (ko) 2007-02-22
DE60006097D1 (de) 2003-11-27
SK285780B6 (sk) 2007-08-02
MXPA01011420A (es) 2002-06-04
BG64442B1 (en) 2005-02-28
BR0010406A (pt) 2002-02-13
CZ290734B6 (cs) 2002-10-16
ZA200108958B (en) 2002-10-30
DK1052243T3 (da) 2003-11-24
PT1177167E (pt) 2004-03-31
EA200000410A2 (ru) 2000-12-25
EE04638B1 (et) 2006-06-15
EA200000411A2 (ru) 2000-12-25
JP2002544184A (ja) 2002-12-24
IL146421A0 (en) 2002-07-25
WO2000068181A3 (en) 2001-06-28
ES2203373T3 (es) 2004-04-16
HK1031372A1 (en) 2001-06-15
DK1177166T3 (da) 2008-06-16
DE60002117D1 (de) 2003-05-22
MY123523A (en) 2006-05-31
CZ20001722A3 (cs) 2000-12-13
DE60004126D1 (de) 2003-09-04
EE200100595A (et) 2003-02-17
NO20015336L (no) 2002-01-08
AU4600300A (en) 2000-11-21
CN1325465C (zh) 2007-07-11
BR0010412A (pt) 2002-02-13
DE60038112T2 (de) 2009-02-12
HU9901559D0 (en) 1999-07-28
SK285635B6 (sk) 2007-05-03
HRP20000291A2 (en) 2001-06-30
CZ20014050A3 (cs) 2002-05-15
NO20015352D0 (no) 2001-11-01
EA200000410A3 (ru) 2001-02-26
SI1177167T1 (en) 2004-04-30
HUP9901559A2 (hu) 2002-01-28
WO2000068183A3 (en) 2001-07-26
UA61122C2 (uk) 2003-11-17
DE60038112T8 (de) 2009-05-28
JP4536265B2 (ja) 2010-09-01
CZ20001723A3 (cs) 2000-12-13
AR023900A1 (es) 2002-09-04
US6624201B2 (en) 2003-09-23
US6242386B1 (en) 2001-06-05
ES2194643T3 (es) 2003-12-01
EP1177166A2 (de) 2002-02-06
US6335469B1 (en) 2002-01-01
IL146421A (en) 2008-11-26
KR20060010874A (ko) 2006-02-02
ATE246170T1 (de) 2003-08-15
CA2369393A1 (en) 2000-11-16
CA2369393C (en) 2010-07-06
DK1052245T3 (da) 2003-08-11

Similar Documents

Publication Publication Date Title
CA2335065A1 (en) Pharmaceutical formulations for aerosols with two or more active substances
IL145958A0 (en) Polymorphic form of arginine salt of (2s)-3-[4-[2-phenoxazin-10-yl)ethoxy] phenyl]2-ethoxypropanoic acid, processes for the preparation thereof and pharmaceutical compositions containing the same
DK1177167T3 (da) (1R,2S,4R)-(-)-2-[(2'-[(N,N,-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptan med høj renhed og farmaceutisk acceptable syreadditionssalte deraf, fremgangsmåde til fremstilling af disse forbindelser og medikamenter, der inde...
IL152005A0 (en) Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and and pharmaceutical preparations containing them
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them